

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.88318309 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.88318309 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 4.65171560 |
| 4 | response to peptidoglycan (GO:0032494) | 4.59758564 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.50563109 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.50563109 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.48061263 |
| 8 | definitive hemopoiesis (GO:0060216) | 4.38611556 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 4.33412922 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97894477 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78659672 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75685071 |
| 13 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69903828 |
| 14 | detection of other organism (GO:0098543) | 3.67644806 |
| 15 | germinal center formation (GO:0002467) | 3.67477482 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.64597454 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54974289 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.53824124 |
| 19 | detection of bacterium (GO:0016045) | 3.50570286 |
| 20 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.50340726 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 3.50340726 |
| 22 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49053003 |
| 23 | megakaryocyte development (GO:0035855) | 3.48192366 |
| 24 | leukocyte aggregation (GO:0070486) | 3.47234164 |
| 25 | cellular extravasation (GO:0045123) | 3.41400703 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.37484737 |
| 27 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.36512524 |
| 28 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36296866 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.33304471 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.32903146 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.32734872 |
| 32 | tolerance induction (GO:0002507) | 3.32485820 |
| 33 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.32012993 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29064362 |
| 35 | regulation of erythrocyte differentiation (GO:0045646) | 3.26913220 |
| 36 | regulation of hypersensitivity (GO:0002883) | 3.25586477 |
| 37 | negative regulation of phagocytosis (GO:0050765) | 3.24664027 |
| 38 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.24202328 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21289411 |
| 40 | negative regulation of granulocyte differentiation (GO:0030853) | 3.16831587 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14653789 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.14653789 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14653789 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14653789 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14653789 |
| 46 | modulation by symbiont of host immune response (GO:0052553) | 3.14653789 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.14334349 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.12026038 |
| 49 | positive regulation of interferon-alpha production (GO:0032727) | 3.11639027 |
| 50 | detection of external biotic stimulus (GO:0098581) | 3.09613473 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08869044 |
| 52 | detection of molecule of bacterial origin (GO:0032490) | 3.08650020 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07569826 |
| 54 | T cell migration (GO:0072678) | 3.06717193 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 3.04438942 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.03935983 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03264848 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03109058 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.02129992 |
| 60 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98804182 |
| 61 | valine metabolic process (GO:0006573) | 2.98501853 |
| 62 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97722642 |
| 63 | positive regulation of type 2 immune response (GO:0002830) | 2.94176765 |
| 64 | regulation of interferon-alpha production (GO:0032647) | 2.92257277 |
| 65 | response to host immune response (GO:0052572) | 2.90824672 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.90824672 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 2.90295262 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90004647 |
| 69 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.87909692 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 2.87831884 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87334760 |
| 72 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85684524 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 2.84523669 |
| 74 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.83512118 |
| 75 | protein carboxylation (GO:0018214) | 2.83512118 |
| 76 | negative thymic T cell selection (GO:0045060) | 2.82846345 |
| 77 | regulation of type 2 immune response (GO:0002828) | 2.82243177 |
| 78 | granulocyte activation (GO:0036230) | 2.81684574 |
| 79 | detection of biotic stimulus (GO:0009595) | 2.81463456 |
| 80 | positive regulation of leukocyte degranulation (GO:0043302) | 2.81355285 |
| 81 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81016573 |
| 82 | negative regulation of interleukin-6 production (GO:0032715) | 2.80908331 |
| 83 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.78553229 |
| 84 | response to interleukin-15 (GO:0070672) | 2.76111767 |
| 85 | complement activation, alternative pathway (GO:0006957) | 2.75854291 |
| 86 | mannose metabolic process (GO:0006013) | 2.75790891 |
| 87 | negative regulation of type 2 immune response (GO:0002829) | 2.74847708 |
| 88 | macrophage activation (GO:0042116) | 2.74312653 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74159553 |
| 90 | myeloid dendritic cell activation (GO:0001773) | 2.73419761 |
| 91 | regulation of antigen processing and presentation (GO:0002577) | 2.72721794 |
| 92 | response to host defenses (GO:0052200) | 2.72354941 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72354941 |
| 94 | response to host (GO:0075136) | 2.72354941 |
| 95 | urea metabolic process (GO:0019627) | 2.72098078 |
| 96 | urea cycle (GO:0000050) | 2.72098078 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.72037386 |
| 98 | response to interferon-alpha (GO:0035455) | 2.71903254 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71631390 |
| 100 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.71242867 |
| 101 | pinocytosis (GO:0006907) | 2.71113271 |
| 102 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70801418 |
| 103 | regulation of interleukin-12 production (GO:0032655) | 2.70067708 |
| 104 | T-helper 1 type immune response (GO:0042088) | 2.69191599 |
| 105 | negative T cell selection (GO:0043383) | 2.68049230 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.67867073 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.67463974 |
| 108 | neutrophil activation (GO:0042119) | 2.67199996 |
| 109 | response to type I interferon (GO:0034340) | 2.67135841 |
| 110 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66988905 |
| 111 | B cell receptor signaling pathway (GO:0050853) | 2.66137769 |
| 112 | thrombin receptor signaling pathway (GO:0070493) | 2.66033475 |
| 113 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.65905064 |
| 114 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65479481 |
| 115 | T cell selection (GO:0045058) | 2.64783767 |
| 116 | regulation of chronic inflammatory response (GO:0002676) | 2.64371934 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.64060401 |
| 118 | positive regulation of protein deacetylation (GO:0090312) | 2.62298905 |
| 119 | type I interferon signaling pathway (GO:0060337) | 2.60813565 |
| 120 | cellular response to type I interferon (GO:0071357) | 2.60813565 |
| 121 | embryonic hemopoiesis (GO:0035162) | 2.60298976 |
| 122 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.59903734 |
| 123 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56824925 |
| 124 | angiotensin maturation (GO:0002003) | 2.56627202 |
| 125 | regulation of necroptotic process (GO:0060544) | 2.56193442 |
| 126 | erythrocyte maturation (GO:0043249) | 2.55757117 |
| 127 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54540852 |
| 128 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.54245569 |
| 129 | natural killer cell differentiation (GO:0001779) | 2.52635292 |
| 130 | positive regulation of macrophage differentiation (GO:0045651) | 2.51117655 |
| 131 | interferon-gamma production (GO:0032609) | 2.50485813 |
| 132 | B cell mediated immunity (GO:0019724) | 2.48177374 |
| 133 | germ cell migration (GO:0008354) | 2.44516604 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.43301255 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.41533154 |
| 136 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.41176933 |
| 137 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.39927840 |
| 138 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.39810944 |
| 139 | regulation of protein activation cascade (GO:2000257) | 2.37540581 |
| 140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.36394722 |
| 141 | regulation of cholesterol storage (GO:0010885) | 2.36052104 |
| 142 | nitrogen cycle metabolic process (GO:0071941) | 2.36020805 |
| 143 | T cell homeostasis (GO:0043029) | 2.35218888 |
| 144 | plasma lipoprotein particle assembly (GO:0034377) | 2.34748532 |
| 145 | gland morphogenesis (GO:0022612) | 2.33635071 |
| 146 | macrophage activation involved in immune response (GO:0002281) | 2.32462357 |
| 147 | protein-lipid complex assembly (GO:0065005) | 2.30207863 |
| 148 | complement activation, classical pathway (GO:0006958) | 2.30088746 |
| 149 | regulation of phagocytosis (GO:0050764) | 2.29832244 |
| 150 | phospholipid efflux (GO:0033700) | 2.29649894 |
| 151 | response to protozoan (GO:0001562) | 2.29161797 |
| 152 | regulation of complement activation (GO:0030449) | 2.28960943 |
| 153 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.28857785 |
| 154 | complement activation (GO:0006956) | 2.28603901 |
| 155 | sulfur amino acid catabolic process (GO:0000098) | 2.28255562 |
| 156 | positive regulation of developmental pigmentation (GO:0048087) | 2.26492832 |
| 157 | blood coagulation, intrinsic pathway (GO:0007597) | 2.26234580 |
| 158 | negative regulation of fibrinolysis (GO:0051918) | 2.24590963 |
| 159 | mast cell activation (GO:0045576) | 2.24470344 |
| 160 | alpha-linolenic acid metabolic process (GO:0036109) | 2.24170871 |
| 161 | protein activation cascade (GO:0072376) | 2.23936669 |
| 162 | defense response to protozoan (GO:0042832) | 2.23718776 |
| 163 | indolalkylamine catabolic process (GO:0046218) | 2.23291246 |
| 164 | tryptophan catabolic process (GO:0006569) | 2.23291246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46482289 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26789863 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.95177372 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81120628 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.57608894 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01351017 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97928111 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.97794478 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.78794892 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54582715 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54411762 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53607013 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52495682 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52017517 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.50731784 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.46409036 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45058302 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31767135 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.31700798 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29463913 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.28304979 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25820347 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20475052 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.19125493 |
| 25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18907872 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06790285 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05308514 |
| 28 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.99752009 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96191786 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96143277 |
| 31 | * MAF_26560356_Chip-Seq_TH1_Human | 1.93162121 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90062160 |
| 33 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89847961 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89239772 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88607176 |
| 36 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.81284153 |
| 37 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.80427685 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.74474081 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.70795511 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70631686 |
| 41 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.69473673 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68299059 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66497175 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65465118 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64098110 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.63760862 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61464399 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57703506 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56267388 |
| 50 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.54657088 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52956059 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52260983 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51913693 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50583187 |
| 55 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49830173 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49768111 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.48871390 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47911277 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46706833 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46215142 |
| 61 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43116708 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42883259 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42732256 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40484761 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37279756 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36893842 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36282555 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.34672001 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34258365 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34119233 |
| 71 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.31065123 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30428833 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28694299 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25517217 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25165713 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22720990 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22451784 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22422966 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21575527 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20343467 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18820237 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18449047 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17907177 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17109665 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16443089 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16264951 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16091882 |
| 88 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15573572 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14985710 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12775662 |
| 91 | * MAF_26560356_Chip-Seq_TH2_Human | 1.11431554 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09863062 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09199006 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07800216 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06895159 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05377642 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02518965 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02437584 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01836890 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01797988 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00716985 |
| 102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99741505 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98572010 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98448799 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98216218 |
| 106 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97893279 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97231865 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97152861 |
| 109 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96221979 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95694020 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94928190 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92935933 |
| 113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92399727 |
| 114 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91636173 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91535899 |
| 116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91216772 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90667058 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90142473 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88177236 |
| 120 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86455707 |
| 121 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86081831 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.84370355 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84173547 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83514518 |
| 125 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82429356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 2.96876963 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 2.82859445 |
| 3 | MP0005075_abnormal_melanosome_morpholog | 2.54564159 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.52982869 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.42465490 |
| 6 | MP0005360_urolithiasis | 2.31121996 |
| 7 | MP0009840_abnormal_foam_cell | 2.27979860 |
| 8 | MP0004510_myositis | 2.24869210 |
| 9 | * MP0003436_decreased_susceptibility_to | 2.21747815 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.18213707 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.05157914 |
| 12 | MP0001800_abnormal_humoral_immune | 2.04983565 |
| 13 | MP0005365_abnormal_bile_salt | 2.03738831 |
| 14 | * MP0005025_abnormal_response_to | 2.00071145 |
| 15 | MP0003303_peritoneal_inflammation | 1.98549501 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 1.97592479 |
| 17 | MP0000685_abnormal_immune_system | 1.95146887 |
| 18 | MP0002419_abnormal_innate_immunity | 1.94660438 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.94366459 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 1.90001145 |
| 21 | MP0000465_gastrointestinal_hemorrhage | 1.89859313 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.88269668 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.88269668 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.88228126 |
| 25 | MP0005387_immune_system_phenotype | 1.87769748 |
| 26 | MP0001790_abnormal_immune_system | 1.87769748 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.83579559 |
| 28 | MP0006054_spinal_hemorrhage | 1.83102680 |
| 29 | * MP0005000_abnormal_immune_tolerance | 1.78752981 |
| 30 | MP0009278_abnormal_bone_marrow | 1.77999456 |
| 31 | MP0005671_abnormal_response_to | 1.73996360 |
| 32 | MP0002398_abnormal_bone_marrow | 1.72119751 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.69869294 |
| 34 | MP0002723_abnormal_immune_serum | 1.69036043 |
| 35 | * MP0002420_abnormal_adaptive_immunity | 1.65482865 |
| 36 | * MP0001819_abnormal_immune_cell | 1.64170487 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.60729096 |
| 38 | MP0009785_altered_susceptibility_to | 1.60070390 |
| 39 | MP0005310_abnormal_salivary_gland | 1.59035219 |
| 40 | MP0008260_abnormal_autophagy | 1.56756221 |
| 41 | MP0006082_CNS_inflammation | 1.56648689 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.55317110 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.52788337 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.52145274 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.52056877 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.51290696 |
| 47 | MP0003252_abnormal_bile_duct | 1.50396978 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.48628328 |
| 49 | MP0003075_altered_response_to | 1.48614342 |
| 50 | MP0002722_abnormal_immune_system | 1.46679937 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.45747765 |
| 52 | * MP0000716_abnormal_immune_system | 1.45510512 |
| 53 | MP0000490_abnormal_crypts_of | 1.44684106 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.44314171 |
| 55 | MP0001853_heart_inflammation | 1.41709488 |
| 56 | MP0002405_respiratory_system_inflammati | 1.41559273 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.39108727 |
| 58 | * MP0002429_abnormal_blood_cell | 1.39086473 |
| 59 | MP0000604_amyloidosis | 1.35407588 |
| 60 | MP0000609_abnormal_liver_physiology | 1.34236231 |
| 61 | MP0004947_skin_inflammation | 1.33587450 |
| 62 | MP0008469_abnormal_protein_level | 1.33049817 |
| 63 | MP0008004_abnormal_stomach_pH | 1.32816244 |
| 64 | MP0003828_pulmonary_edema | 1.31728446 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.28387609 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27494015 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.25370156 |
| 68 | MP0003763_abnormal_thymus_physiology | 1.24979990 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.23482655 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.22198308 |
| 71 | MP0001873_stomach_inflammation | 1.21721119 |
| 72 | MP0005083_abnormal_biliary_tract | 1.21250909 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.21177699 |
| 74 | MP0003448_altered_tumor_morphology | 1.20798407 |
| 75 | MP0000343_altered_response_to | 1.19341474 |
| 76 | MP0001915_intracranial_hemorrhage | 1.18059842 |
| 77 | MP0003724_increased_susceptibility_to | 1.15208054 |
| 78 | MP0010307_abnormal_tumor_latency | 1.14596233 |
| 79 | MP0001851_eye_inflammation | 1.13732734 |
| 80 | MP0003091_abnormal_cell_migration | 1.13586745 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.13106879 |
| 82 | * MP0001533_abnormal_skeleton_physiology | 1.12412025 |
| 83 | MP0000598_abnormal_liver_morphology | 1.11082649 |
| 84 | MP0005166_decreased_susceptibility_to | 1.07258447 |
| 85 | MP0009763_increased_sensitivity_to | 1.06268330 |
| 86 | MP0009764_decreased_sensitivity_to | 1.06000859 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 1.05104610 |
| 88 | MP0003566_abnormal_cell_adhesion | 1.04208384 |
| 89 | MP0004130_abnormal_muscle_cell | 1.01732762 |
| 90 | * MP0005390_skeleton_phenotype | 0.99598965 |
| 91 | MP0002006_tumorigenesis | 0.98432968 |
| 92 | MP0003690_abnormal_glial_cell | 0.97357134 |
| 93 | MP0002254_reproductive_system_inflammat | 0.96057960 |
| 94 | MP0004883_abnormal_blood_vessel | 0.95008603 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.94507158 |
| 96 | MP0000858_altered_metastatic_potential | 0.93923627 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.92065693 |
| 98 | MP0003866_abnormal_defecation | 0.91660869 |
| 99 | MP0002928_abnormal_bile_duct | 0.90979647 |
| 100 | MP0005164_abnormal_response_to | 0.90972260 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.90946125 |
| 102 | MP0005451_abnormal_body_composition | 0.90907261 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.85868959 |
| 104 | MP0001663_abnormal_digestive_system | 0.84756574 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.84625949 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.84445166 |
| 107 | MP0004147_increased_porphyrin_level | 0.82775762 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.81821999 |
| 109 | MP0000767_abnormal_smooth_muscle | 0.81671028 |
| 110 | MP0003795_abnormal_bone_structure | 0.81522764 |
| 111 | MP0003279_aneurysm | 0.80524718 |
| 112 | MP0000371_diluted_coat_color | 0.80291422 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.78563437 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.77142944 |
| 115 | MP0002132_abnormal_respiratory_system | 0.75756190 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.72883398 |
| 117 | MP0000249_abnormal_blood_vessel | 0.71860360 |
| 118 | MP0005076_abnormal_cell_differentiation | 0.71856786 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.71478946 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.71448149 |
| 121 | MP0005023_abnormal_wound_healing | 0.69594977 |
| 122 | MP0008874_decreased_physiological_sensi | 0.69322332 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.68834853 |
| 124 | MP0002933_joint_inflammation | 0.68566344 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68002539 |
| 126 | MP0009115_abnormal_fat_cell | 0.67794545 |
| 127 | MP0001542_abnormal_bone_strength | 0.67532160 |
| 128 | MP0003329_amyloid_beta_deposits | 0.66007960 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.62295131 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.60388439 |
| 131 | MP0000920_abnormal_myelination | 0.57449706 |
| 132 | MP0001849_ear_inflammation | 0.57108939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.68618977 |
| 2 | Optic neuritis (HP:0100653) | 4.40371936 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.40371936 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.19487712 |
| 5 | Petechiae (HP:0000967) | 3.97682880 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95717796 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95717796 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95717796 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.63717318 |
| 10 | Loss of speech (HP:0002371) | 3.45457737 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.43987336 |
| 12 | Gingival bleeding (HP:0000225) | 3.43751694 |
| 13 | Complement deficiency (HP:0004431) | 3.43719788 |
| 14 | IgM deficiency (HP:0002850) | 3.29146461 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27207137 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.26105106 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.19013894 |
| 18 | Abnormal platelet function (HP:0011869) | 3.17831043 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.17831043 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.17761024 |
| 21 | Increased IgE level (HP:0003212) | 3.13467984 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.09207433 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.08211665 |
| 24 | Nasal polyposis (HP:0100582) | 3.03456651 |
| 25 | Epistaxis (HP:0000421) | 3.01374748 |
| 26 | Joint hemorrhage (HP:0005261) | 3.00287857 |
| 27 | Keratoconjunctivitis (HP:0001096) | 2.99648599 |
| 28 | Recurrent viral infections (HP:0004429) | 2.92648312 |
| 29 | Abnormality of complement system (HP:0005339) | 2.91577756 |
| 30 | Thrombocytosis (HP:0001894) | 2.89836666 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.88933513 |
| 32 | Gingivitis (HP:0000230) | 2.88358805 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 2.88109445 |
| 34 | Glomerulonephritis (HP:0000099) | 2.87832254 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83790282 |
| 36 | Obstructive lung disease (HP:0006536) | 2.83790282 |
| 37 | Chronic otitis media (HP:0000389) | 2.83787948 |
| 38 | Myositis (HP:0100614) | 2.80254297 |
| 39 | Purpura (HP:0000979) | 2.80107706 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.79894060 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.78773968 |
| 42 | Cellulitis (HP:0100658) | 2.78047750 |
| 43 | T lymphocytopenia (HP:0005403) | 2.77909777 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.74755227 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69874246 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69874246 |
| 47 | Increased mean platelet volume (HP:0011877) | 2.69725104 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.65230929 |
| 49 | Menorrhagia (HP:0000132) | 2.63918166 |
| 50 | Myocardial infarction (HP:0001658) | 2.60110759 |
| 51 | Amyloidosis (HP:0011034) | 2.59311653 |
| 52 | Poikilocytosis (HP:0004447) | 2.57917337 |
| 53 | Encephalitis (HP:0002383) | 2.55347933 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.53645050 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.51846039 |
| 56 | Hemoptysis (HP:0002105) | 2.48628570 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.48421343 |
| 58 | Increased IgM level (HP:0003496) | 2.46882497 |
| 59 | Spastic diplegia (HP:0001264) | 2.46085093 |
| 60 | Hematochezia (HP:0002573) | 2.41840914 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.36266494 |
| 62 | Colitis (HP:0002583) | 2.33153327 |
| 63 | Leukocytosis (HP:0001974) | 2.30910552 |
| 64 | Prolonged partial thromboplastin time (HP:0003645) | 2.28663162 |
| 65 | Cerebral aneurysm (HP:0004944) | 2.25750717 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.24282110 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.23788102 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.23450606 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.21468926 |
| 70 | Nephritis (HP:0000123) | 2.21054731 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21034769 |
| 72 | Inflammation of the large intestine (HP:0002037) | 2.19988871 |
| 73 | Abnormality of T cells (HP:0002843) | 2.19682165 |
| 74 | Mediastinal lymphadenopathy (HP:0100721) | 2.18665985 |
| 75 | Hypochromic anemia (HP:0001931) | 2.17389106 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.17145795 |
| 77 | Xanthomatosis (HP:0000991) | 2.16685307 |
| 78 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15286678 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13956154 |
| 80 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13789585 |
| 81 | Reduced antithrombin III activity (HP:0001976) | 2.13475565 |
| 82 | Recurrent skin infections (HP:0001581) | 2.11737343 |
| 83 | Gangrene (HP:0100758) | 2.10841681 |
| 84 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.10248270 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.08718916 |
| 86 | Episodic fever (HP:0001954) | 2.07966165 |
| 87 | Neuronal loss in central nervous system (HP:0002529) | 2.06814080 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.05606430 |
| 89 | Spondylolisthesis (HP:0003302) | 2.04999037 |
| 90 | Anorexia (HP:0002039) | 2.04744440 |
| 91 | Peritonitis (HP:0002586) | 2.04305140 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 2.02585521 |
| 93 | Autoimmune hemolytic anemia (HP:0001890) | 2.01025442 |
| 94 | Disinhibition (HP:0000734) | 2.00405332 |
| 95 | Periodontitis (HP:0000704) | 1.99953174 |
| 96 | Acne (HP:0001061) | 1.99584143 |
| 97 | Microcytic anemia (HP:0001935) | 1.99493883 |
| 98 | Granulocytopenia (HP:0001913) | 1.99192954 |
| 99 | Polyneuropathy (HP:0001271) | 1.98408454 |
| 100 | Increased serum ferritin (HP:0003281) | 1.98241288 |
| 101 | Pulmonary embolism (HP:0002204) | 1.98193265 |
| 102 | Lymphopenia (HP:0001888) | 1.97952713 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 1.97300526 |
| 104 | Acanthocytosis (HP:0001927) | 1.94969701 |
| 105 | Pustule (HP:0200039) | 1.94919130 |
| 106 | Osteomyelitis (HP:0002754) | 1.94880599 |
| 107 | Thoracic kyphosis (HP:0002942) | 1.94161281 |
| 108 | Orchitis (HP:0100796) | 1.94071945 |
| 109 | Hypercholesterolemia (HP:0003124) | 1.93831920 |
| 110 | Vasculitis (HP:0002633) | 1.93510128 |
| 111 | Intrahepatic cholestasis (HP:0001406) | 1.92178779 |
| 112 | Thin bony cortex (HP:0002753) | 1.92061329 |
| 113 | Hyperlipoproteinemia (HP:0010980) | 1.91725115 |
| 114 | Glomerulopathy (HP:0100820) | 1.91504762 |
| 115 | Polygenic inheritance (HP:0010982) | 1.91489192 |
| 116 | Joint swelling (HP:0001386) | 1.91294070 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.91274971 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 1.90788912 |
| 119 | Chest pain (HP:0100749) | 1.90746558 |
| 120 | Panhypogammaglobulinemia (HP:0003139) | 1.90260045 |
| 121 | Emphysema (HP:0002097) | 1.89798218 |
| 122 | Aplastic anemia (HP:0001915) | 1.89192016 |
| 123 | Restrictive lung disease (HP:0002091) | 1.88349818 |
| 124 | High pitched voice (HP:0001620) | 1.87759326 |
| 125 | Urticaria (HP:0001025) | 1.87584421 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.87524834 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87524834 |
| 128 | Bruising susceptibility (HP:0000978) | 1.86688530 |
| 129 | Meningitis (HP:0001287) | 1.86613074 |
| 130 | Mutism (HP:0002300) | 1.86476367 |
| 131 | Prominent nose (HP:0000448) | 1.86374563 |
| 132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85701544 |
| 133 | Abnormality of macrophages (HP:0004311) | 1.84659549 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84098757 |
| 135 | Dysostosis multiplex (HP:0000943) | 1.84020573 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.83997902 |
| 137 | Abnormality of the pleura (HP:0002103) | 1.83595136 |
| 138 | Neurofibrillary tangles (HP:0002185) | 1.83583929 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.83539760 |
| 140 | Arterial thrombosis (HP:0004420) | 1.82751904 |
| 141 | Hyperacusis (HP:0010780) | 1.79331835 |
| 142 | Reticulocytosis (HP:0001923) | 1.79303675 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79230395 |
| 144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78315703 |
| 145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78315703 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78315703 |
| 147 | Viral hepatitis (HP:0006562) | 1.77853508 |
| 148 | Hepatocellular carcinoma (HP:0001402) | 1.77831430 |
| 149 | Aortic aneurysm (HP:0004942) | 1.76857953 |
| 150 | Mitral stenosis (HP:0001718) | 1.76308849 |
| 151 | Hyperbilirubinemia (HP:0002904) | 1.75331780 |
| 152 | Gastrointestinal stroma tumor (HP:0100723) | 1.71607775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.70048274 |
| 2 | ERN1 | 3.40906083 |
| 3 | KIT | 3.23960300 |
| 4 | MAP4K1 | 3.18118418 |
| 5 | EEF2K | 3.09972477 |
| 6 | TRIB3 | 2.59494413 |
| 7 | TYK2 | 2.53544489 |
| 8 | TGFBR2 | 2.51861927 |
| 9 | PKN2 | 2.40928802 |
| 10 | CSF1R | 2.37021944 |
| 11 | TBK1 | 2.17494079 |
| 12 | CDK12 | 2.14383688 |
| 13 | SIK1 | 2.02903327 |
| 14 | TAOK3 | 1.97436587 |
| 15 | PTK6 | 1.92485436 |
| 16 | ZAP70 | 1.87929156 |
| 17 | MAP3K3 | 1.87188083 |
| 18 | TAOK2 | 1.81326561 |
| 19 | CLK1 | 1.78729819 |
| 20 | MAP2K3 | 1.72318693 |
| 21 | BTK | 1.61479552 |
| 22 | JAK3 | 1.61299829 |
| 23 | TAOK1 | 1.57838927 |
| 24 | BLK | 1.57725455 |
| 25 | MAP3K13 | 1.56976572 |
| 26 | MATK | 1.53501351 |
| 27 | IKBKE | 1.52613365 |
| 28 | GRK6 | 1.49952572 |
| 29 | FLT3 | 1.49051089 |
| 30 | MAP3K10 | 1.47739020 |
| 31 | SIK3 | 1.46435318 |
| 32 | PAK4 | 1.40437692 |
| 33 | CAMK1D | 1.39811374 |
| 34 | CDK6 | 1.35960624 |
| 35 | GRK7 | 1.34254118 |
| 36 | FGFR4 | 1.32766995 |
| 37 | TIE1 | 1.30757346 |
| 38 | CDC42BPA | 1.27215999 |
| 39 | KSR2 | 1.27018659 |
| 40 | TNK2 | 1.26319399 |
| 41 | IRAK4 | 1.23183707 |
| 42 | MAP3K1 | 1.20194678 |
| 43 | STK10 | 1.19939944 |
| 44 | SMG1 | 1.19875795 |
| 45 | FGR | 1.17463094 |
| 46 | JAK1 | 1.14413783 |
| 47 | LRRK2 | 1.12552686 |
| 48 | FGFR3 | 1.09983265 |
| 49 | RPS6KA4 | 1.08033571 |
| 50 | BCKDK | 1.07881353 |
| 51 | SYK | 1.05554643 |
| 52 | MAP3K14 | 1.04827043 |
| 53 | NME2 | 1.04348432 |
| 54 | RIPK1 | 1.03498960 |
| 55 | IKBKB | 1.03274061 |
| 56 | JAK2 | 1.01774527 |
| 57 | TEC | 1.00689008 |
| 58 | CAMK1G | 0.97188546 |
| 59 | NEK2 | 0.96404620 |
| 60 | PRKD2 | 0.95166225 |
| 61 | MARK2 | 0.95160819 |
| 62 | TTN | 0.92683306 |
| 63 | IRAK3 | 0.92464403 |
| 64 | TRPM7 | 0.89546194 |
| 65 | CHUK | 0.89530371 |
| 66 | MOS | 0.89529342 |
| 67 | DDR2 | 0.88646896 |
| 68 | CSK | 0.87684800 |
| 69 | TTK | 0.87563608 |
| 70 | BMPR2 | 0.86563942 |
| 71 | TXK | 0.86455177 |
| 72 | IRAK1 | 0.85063157 |
| 73 | CDK4 | 0.85035321 |
| 74 | SIK2 | 0.84658438 |
| 75 | FES | 0.82740760 |
| 76 | PIM1 | 0.82552200 |
| 77 | CAMKK2 | 0.81382194 |
| 78 | TGFBR1 | 0.79743640 |
| 79 | LYN | 0.79066446 |
| 80 | HCK | 0.78439362 |
| 81 | MAP3K7 | 0.78297248 |
| 82 | ITK | 0.76925267 |
| 83 | LCK | 0.76855272 |
| 84 | RIPK4 | 0.75752833 |
| 85 | CAMKK1 | 0.75004571 |
| 86 | PDK1 | 0.74120827 |
| 87 | EPHA3 | 0.73293524 |
| 88 | MAPK7 | 0.73176577 |
| 89 | EPHB1 | 0.73106192 |
| 90 | STK3 | 0.72271722 |
| 91 | IRAK2 | 0.71602515 |
| 92 | MAPK11 | 0.70881809 |
| 93 | PDPK1 | 0.68797896 |
| 94 | MAP3K11 | 0.68644733 |
| 95 | BMX | 0.66170343 |
| 96 | TYRO3 | 0.61096910 |
| 97 | ICK | 0.61012674 |
| 98 | STK4 | 0.60429992 |
| 99 | NEK9 | 0.58215279 |
| 100 | MAPKAPK3 | 0.53942887 |
| 101 | HIPK2 | 0.53821103 |
| 102 | CAMK4 | 0.53759910 |
| 103 | MTOR | 0.52676703 |
| 104 | DYRK3 | 0.52388666 |
| 105 | RPS6KB2 | 0.52327532 |
| 106 | SCYL2 | 0.52173189 |
| 107 | RPS6KA6 | 0.51286905 |
| 108 | MAP3K5 | 0.51008817 |
| 109 | ERBB2 | 0.49391308 |
| 110 | EGFR | 0.49354454 |
| 111 | MARK3 | 0.47394149 |
| 112 | MAP3K6 | 0.46926718 |
| 113 | DYRK1B | 0.46432385 |
| 114 | NEK1 | 0.46028004 |
| 115 | KDR | 0.45630012 |
| 116 | CDK7 | 0.45538538 |
| 117 | ATR | 0.42915234 |
| 118 | MAP3K2 | 0.42126157 |
| 119 | SGK3 | 0.42020188 |
| 120 | MAPK4 | 0.41480195 |
| 121 | PIM2 | 0.41006306 |
| 122 | PDGFRA | 0.40864230 |
| 123 | RET | 0.40355296 |
| 124 | GRK1 | 0.39507848 |
| 125 | PRKAA2 | 0.39473807 |
| 126 | TESK2 | 0.39254935 |
| 127 | PAK2 | 0.38601245 |
| 128 | YES1 | 0.37390693 |
| 129 | MAPKAPK2 | 0.37097262 |
| 130 | BRD4 | 0.35995999 |
| 131 | RPS6KA2 | 0.35668520 |
| 132 | MAPK12 | 0.33458841 |
| 133 | RPS6KL1 | 0.32967674 |
| 134 | RPS6KC1 | 0.32967674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.13706572 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50321425 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46857345 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15125880 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.07063254 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97410019 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94597739 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.88940031 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.83897067 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81781381 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80341925 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72921351 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65568145 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60631398 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58039199 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50124070 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48677893 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47242087 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.47210038 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46040854 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.45559739 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42703557 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.39964422 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39694770 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39216008 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.39204475 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39165386 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38585124 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34515650 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34474818 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33455011 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32287587 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30876408 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.25390711 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24642819 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24109377 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23699624 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.21888671 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21433727 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21207482 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.19138558 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.19002651 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.18490745 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18461597 |
| 45 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15490061 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14220566 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12904923 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12354969 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09383555 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08460512 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08320709 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07706600 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 1.03892957 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03319025 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.03160452 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.02073200 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.01113642 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98290709 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97141825 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96094994 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.95883779 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94869433 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.94813249 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.93947357 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.92992410 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90808433 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.89772433 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.89768936 |
| 69 | DNA replication_Homo sapiens_hsa03030 | 0.88859359 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87160159 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84754741 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83360611 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83290240 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81319540 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80256896 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.80170841 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79235247 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79080892 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77940631 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.77578543 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.77306479 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76883501 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.76733720 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75216478 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75197588 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74138454 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71901541 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71712778 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70465950 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70089148 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69826593 |
| 92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68981860 |
| 93 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68851511 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68275872 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67003868 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65007238 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64496521 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61314025 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61291413 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61109596 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61014017 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60210408 |
| 103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59703295 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.59610357 |
| 105 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59182143 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58287027 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.58100514 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57394054 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56552856 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56289294 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56217377 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55537681 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54882415 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53482656 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.53059729 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52860457 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52447891 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52093023 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51052463 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50838219 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.50536653 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50002380 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.49363631 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49265841 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49016167 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48083764 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47098059 |
| 128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44883617 |
| 129 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44722342 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44100836 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43820918 |
| 132 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43297587 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.43110241 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.42924821 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42384306 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42213349 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42157652 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42156153 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41946749 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40997345 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40128084 |
| 142 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39840664 |
| 143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39250725 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38810436 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38804425 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36627666 |

